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quick intervention of the physician may save the organ from necrosis. The first treatment option 
is to remove the cause of ischemia, but the studies revealed that the reperfusion is able to 
worsen the initial lesions that were only due to disrupted blood flow. The scientists propose 
postconditioning as a technique for reducing the reperfusion injuries.   
Aim of the study.  The aim of the study was to do a research of the specialized literature to 
assure a better understanding of the mechanisms of protection of postconditioning in the 
context of the diseases characterized by ischemia/reperfusion injuries. 
Materials and methods.  Were studied the articles from PubMed database over the last ten 
years describing the mechanisms of ischemia/reperfusion injury in different organs and the 
effects of postconditioning as a method of protection against reperfusion lesions. Were used 
the following keywords: postconditioning, ischemia/reperfusion injury. 
Results.  The reperfusion injuries are due to activation of different metabolic pathways that are 
related to toxic compounds formation, such as reactive oxygen species (ROS), with deleterious 
effects on cell components. The studies revealed that during reperfusion the level of malonic 
dialdehyde, a biomarker for membrane lipid peroxidation, increases, and this is due to a high 
level of ROS. Moreover, the literature related to reperfusion injury emphasizes the role of the 
increased intracellular calcium concentration with activation of different enzymes, the opening 
of the mitochondrial permeability transition pore, inflammation, increased endothelial 
dysfunction, and neutrophils activation. Postconditioning after ischemia involves short-term 
cycles of ischemia that alternate with reperfusion, at the onset of the restoration of the blood 
flow. It was established that the mechanisms of protection are considered to be related to a 
reduction of ROS production, inhibition of mitochondrial permeability transition pore, 
activation of ATP-dependent K-channel through adenosine, which affects the intracellular 
calcium levels, nitric oxide and pro-survival kinase. 
Conclusions.  Postconditioning which represents the gradual restoration of blood flow can 
reduce the extent of reperfusion injury by various mechanisms. The results of the experimental 
studies on different ischemic organs showed that the short episodes of interruption of the blood 
flow from the onset of reperfusion, essentially reduced the size of the lesion, compared to a 
normal revascularization. The postconditioning must be taken into account when there are 
ischemic diseases. 
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Introduction. Type 2 Diabetes mellitus (T2DM) represents a major public health burden and 
a growing prevalent chronic disease around the world. It is known that more than 425 million 
people have diabetes, and this number is expected to rise to over 642 million by 2040. 
Alzheimer’s disease (AD) is the main cause of dementia, affecting over 26 million people 
worldwide, and its prevalence continues to increase. Both conditions are related to age, and in 
the last decades, an interesting link between them has appeared from various studies that affirm 
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that individuals with T2DM are 2–4 times more likely to develop AD, but definitive 
biochemical mechanisms remain unknown.   
Aim of the study. This review has the intention to present that type 2 diabetes mellitus (T2DM) 
is a significant risk factor for cognitive dysfunction or dementia, especially those related to 
Alzheimer's disease   
Materials and methods. For the study were used electronic medical platforms such as PubMed 
Databases, Hinary and other scientific libraries like Google Scholar. It have been selected and 
analyzed 40 articles including manuscripts, reviews, and publications for the last 10 years.   
Results. Of the multiple intersection between T2DM and AD, the most pronounced is the 
insulin resistance, characterized by hyperinsulinemia and hyperglycaemia. Insulin resistance 
decreases glucose metabolism which in turn hyperphosphorylates tau protein causing 
neurofibrillary tangles. In AD, the extracellular accumulation of Aβ plaques, intracellular 
aggregation of hyperphosphorylated tau protein in neurofibrillary tangles (NFTs), and neuronal 
loss occur in the cortex and hippocampus, where are located insulin-dependent receptor GLUT 
4 and insulin-independent receptors GLUT1 and GLUT3. Receptors are affected by the 
abnormal glucose metabolism, and not only, including enzymes like GSK-3, Cdk-5, CK-1 and 
others. The mechanism of influence does not stop here; hyperglycemia can activate K-ATP 
channels that increase cellular excitability and leads to an elevated ISF Aβ. Moreover, insulin 
alteration in diabetes can interrupt brain cholesterol metabolism leading to metabolic 
dysfunction.   
Conclusions. T2DM and AD were earlier considered as two independent metabolic disorders. 
However, the present study has clearly stated the presence of common pathophysiological and 
epidemiological mechanisms, together with signaling pathways that associates a relation 
between these two pathologies. It might be possible that therapeutics for T2DM would be 
effective for AD, but in order to prove that, more investigations are needed. Recently, AD has 
been called Type 3 Diabetes.   
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Introduction.  The incidence and prevalence of tumor pathology are constantly increasing both 
globally and in our country. The implementation of new sensitive, specific and easily 
applicable methods such as tumor markers offers new possibilities in diagnosis, personalized 
treatment and subsequent monitoring.   
Aim of the study.  Presentation of the latest and most promising tumor markers according to 
the latest international studies.   
Materials and methods. It has been carried out the synthesis and analysis of the scientific 
information of the last years in the field of oncology and biomarkers. The targeted population 
studies are large and performed in the most endowed centers, with maximum truthful results. 
The markers with the best results were selected.   
Results. Liquid biopsy is an alternative to current diagnostic methods due to its sensitivity, 
applicability, rapidity and harmlessness to obtain CTC, miRNA, RNA, DNA, exosomes, 
